Savara Inc Amortization of Debt Issuance Costs
Savara Inc (SVRA) reported Amortization of Debt Issuance Costs of $203.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-11
- Savara Inc amortization of debt issuance costs for the quarter ending 2026-06-30 was $43.00K, a 66.67% decline year-over-year.
- Savara Inc amortization of debt issuance costs for the quarter ending 2026-03-31 was $160.00K, a 128.57% increase year-over-year.
- Savara Inc amortization of debt issuance costs for the quarter ending 2025-12-31 was $126.00K, a 85.29% increase year-over-year.
- Savara Inc amortization of debt issuance costs for the quarter ending 2025-09-30 was $128.00K, a 88.24% increase year-over-year.
- Savara Inc amortization of debt issuance costs for fiscal 2025 was $453.00K, a 67.16% increase from fiscal 2024.
- Savara Inc amortization of debt issuance costs for fiscal 2024 was $271.00K, a 0.00% change from fiscal 2023.
- Savara Inc amortization of debt issuance costs for fiscal 2023 was $271.00K, a 18.86% decline from fiscal 2022.
- Savara Inc amortization of debt issuance costs for fiscal 2022 was $334.00K, a 39.49% decline from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $43.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $203.00K 10-Q · filed 2026-08-11 | $329.00K derived: sum of 3 quarters · filed 2026-08-11 | $457.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $160.00K 10-Q · filed 2026-05-12 | $286.00K derived: sum of 2 quarters · filed 2026-05-12 | $414.00K derived: sum of 3 quarters · filed 2026-05-12 | $543.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $126.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $254.00K derived: sum of 2 quarters · filed 2026-03-13 | $383.00K derived: sum of 3 quarters · filed 2026-08-11 | $453.00K 10-K · filed 2026-03-13 |
| 2025-09-30 | $128.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $257.00K derived: sum of 2 quarters · filed 2026-08-11 | $327.00K 10-Q · filed 2025-11-12 | $395.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $199.00K 10-Q · filed 2026-08-11 | $267.00K derived: sum of 3 quarters · filed 2026-08-11 | $335.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $70.00K 10-Q · filed 2026-05-12 | $138.00K derived: sum of 2 quarters · filed 2026-05-12 | $206.00K derived: sum of 3 quarters · filed 2026-05-12 | $273.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $136.00K derived: sum of 2 quarters · filed 2026-03-13 | $203.00K derived: sum of 3 quarters · filed 2026-03-13 | $271.00K 10-K · filed 2026-03-13 |
| 2024-09-30 | $68.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $135.00K derived: sum of 2 quarters · filed 2025-11-12 | $203.00K 10-Q · filed 2025-11-12 | $271.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $135.00K 10-Q · filed 2025-08-13 | $203.00K derived: sum of 3 quarters · filed 2025-08-13 | $271.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $68.00K 10-Q · filed 2025-05-13 | $136.00K derived: sum of 2 quarters · filed 2025-05-13 | $204.00K derived: sum of 3 quarters · filed 2025-05-13 | $271.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $136.00K derived: sum of 2 quarters · filed 2025-03-27 | $203.00K derived: sum of 3 quarters · filed 2025-03-27 | $271.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $68.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $135.00K derived: sum of 2 quarters · filed 2024-11-12 | $203.00K 10-Q · filed 2024-11-12 | $271.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $135.00K 10-Q · filed 2024-08-12 | $203.00K derived: sum of 3 quarters · filed 2024-08-12 | $271.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $68.00K 10-Q · filed 2024-05-09 | $136.00K derived: sum of 2 quarters · filed 2024-05-09 | $204.00K derived: sum of 3 quarters · filed 2024-05-09 | $249.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $136.00K derived: sum of 2 quarters · filed 2024-03-07 | $181.00K derived: sum of 3 quarters · filed 2024-03-07 | $334.00K 10-K · filed 2024-03-07 |
| 2022-09-30 | $68.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $113.00K derived: sum of 2 quarters · filed 2023-11-09 | $266.00K 10-Q · filed 2023-11-09 | $405.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $198.00K 10-Q · filed 2023-08-10 | $337.00K derived: sum of 3 quarters · filed 2023-08-10 | $473.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $153.00K 10-Q · filed 2023-05-15 | $292.00K derived: sum of 2 quarters · filed 2023-05-15 | $428.00K derived: sum of 3 quarters · filed 2023-05-15 | $565.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $275.00K derived: sum of 2 quarters · filed 2023-03-30 | $412.00K derived: sum of 3 quarters · filed 2023-03-30 | $552.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $136.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $273.00K derived: sum of 2 quarters · filed 2022-11-10 | $413.00K 10-Q · filed 2022-11-10 | $539.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $137.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $277.00K 10-Q · filed 2022-08-11 | $403.00K derived: sum of 3 quarters · filed 2022-08-11 | $525.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $140.00K 10-Q · filed 2022-05-11 | $266.00K derived: sum of 2 quarters · filed 2022-05-11 | $388.00K derived: sum of 3 quarters · filed 2022-05-11 | $513.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $126.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $248.00K derived: sum of 2 quarters · filed 2022-03-30 | $373.00K derived: sum of 3 quarters · filed 2022-03-30 | $507.00K 10-K · filed 2022-03-30 |
| 2020-09-30 | $122.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $247.00K derived: sum of 2 quarters · filed 2021-11-12 | $381.00K 10-Q · filed 2021-11-12 | $531.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $259.00K 10-Q · filed 2021-08-12 | $409.00K derived: sum of 3 quarters · filed 2021-08-12 | $549.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $134.00K 10-Q · filed 2021-05-13 | $284.00K derived: sum of 2 quarters · filed 2021-05-13 | $424.00K derived: sum of 3 quarters · filed 2021-05-13 | $569.00K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $290.00K derived: sum of 2 quarters · filed 2021-03-10 | $435.00K derived: sum of 3 quarters · filed 2021-03-10 | $582.00K 10-K · filed 2021-03-10 |
| 2019-09-30 | $140.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $285.00K derived: sum of 2 quarters · filed 2020-11-05 | $432.00K 10-Q · filed 2020-11-05 | $568.00K derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $145.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $292.00K 10-Q · filed 2020-08-06 | $428.00K derived: sum of 3 quarters · filed 2020-08-06 | $537.00K derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $147.00K 10-Q · filed 2020-05-07 | $283.00K derived: sum of 2 quarters · filed 2020-05-07 | $392.00K derived: sum of 3 quarters · filed 2020-05-07 | $506.00K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $136.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $245.00K derived: sum of 2 quarters · filed 2020-03-12 | $359.00K derived: sum of 3 quarters · filed 2020-03-12 | $468.00K 10-K · filed 2020-03-12 |
| 2018-09-30 | $109.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $223.00K derived: sum of 2 quarters · filed 2019-11-07 | $332.00K 10-Q · filed 2019-11-07 | $432.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $114.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $223.00K 10-Q · filed 2019-08-08 | $323.00K derived: sum of 3 quarters · filed 2019-08-08 | $420.00K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $109.00K 10-Q · filed 2019-05-09 | $209.00K derived: sum of 2 quarters · filed 2019-05-09 | $306.00K derived: sum of 3 quarters · filed 2019-05-09 | |
| 2017-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $197.00K derived: sum of 2 quarters · filed 2019-03-13 | $401.00K 10-K · filed 2019-03-13 | |
| 2017-09-30 | $97.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $301.00K 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | $204.00K 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |